XML 120 R94.htm IDEA: XBRL DOCUMENT v3.25.1
Earnings per Share and Stock Plans - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2024
shares
Jun. 30, 2019
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
May 12, 2025
USD ($)
Mar. 24, 2025
$ / shares
Mar. 31, 2022
$ / shares
Mar. 26, 2019
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares not included in the computation of diluted loss per share because they were antidilutive (in shares)         479,000          
Share-based payment arrangement, amount | $     $ 3,578 $ 3,578            
Dividends declared per common share (in dollars per share) | $ / shares     $ 0.07 $ 0.28 $ 0.28 $ 0.28        
Annual dividend rate (in dollars per share) | $ / shares               $ 0.28    
Stock repurchase program, authorized amount | $                   $ 20,000
Treasury stock (in shares)           31,000        
Treasury stock, value | $           $ 1,010        
Additional common shares repurchased (in shares)       293,000            
Common stock aggregate cost | $       $ 9,945            
Restricted Stock Units (RSUs)                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares not included in the computation of diluted loss per share because they were antidilutive (in shares)       1,756,000            
ESOP Debt Guarantee                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares not included in the computation of diluted loss per share because they were antidilutive (in shares)       1,756,000            
Performance Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares not included in the computation of diluted loss per share because they were antidilutive (in shares)       1,756,000            
Subsequent Event                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Dividend distribution declared per preferred share purchase right | $             $ 2,003      
2016 LTIP                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based payment award, number of additional shares authorized (in shares) 2,800,000 2,500,000                
Long Term Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total number of shares of common stock which may be granted under the plan (in shares)     5,300,000 5,300,000            
Long Term Incentive Plan | Cost of Goods Sold, Selling, and General and Administrative                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock based compensation expense | $       $ 6,256 $ 12,039 $ 10,425        
Performance Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common shares not included in the computation of diluted loss per share because they were antidilutive (in shares)         165,000          
Weighted average fair value grant price (in dollars per share) | $ / shares     $ 33.90 $ 33.90 $ 36.13 $ 34.49     $ 35.35  
ESOP Debt Guarantee                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Weighted-average exercise price (in dollars per share) | $ / shares     $ 36.38 $ 36.38 $ 35.37 $ 34.54     $ 33.82  
ESOP Debt Guarantee | Long Term Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares available for future grants (in shares)     2,562,000 2,562,000            
Period options generally become exercisable       3 years            
Vesting percentage       33.00%            
Share based compensation, exercise price, percent of fair market value     1 1            
Number of options outstanding, in-the-money (in shares)     51,957 51,957            
Number of options, exercisable, in-the-money     51,957 51,957            
Closing stock price (in dollars per share) | $ / shares     $ 16.70 $ 16.70            
Total intrinsic value of stock options exercised | $       $ 120 $ 870 $ 360        
Grant date fair value of options that vested (in dollars per share) | $ / shares       $ 11.55 $ 11.00 $ 10.36        
Unrecognized compensation cost related to non-vested stock options | $     $ 2,615 $ 2,615            
Weighted average period of recognition for unrecognized compensation cost       1 year 8 months 12 days            
Weighted-average fair value of options (in dollars per share) | $ / shares       $ 17.13 $ 12.97 $ 11.13        
ESOP Debt Guarantee | Long Term Incentive Plan | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Weighted-average exercise price (in dollars per share) | $ / shares     $ 15.16 15.16            
ESOP Debt Guarantee | Long Term Incentive Plan | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Weighted-average exercise price (in dollars per share) | $ / shares     $ 54.26 $ 54.26            
ESOP Debt Guarantee | Stock Incentive Plan of Magnetek                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares available for future grants (in shares)     164,461 164,461            
Restricted Stock | Long Term Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Weighted average period of recognition for unrecognized compensation cost       1 year 9 months 18 days            
Total unrecognized compensation cost related to unvested restricted stock units | $     $ 3,356 $ 3,356            
Fair value of restricted stock units that vested during the period | $       $ 4,922 $ 5,720          
Restricted Stock | Long Term Incentive Plan | Share-Based Payment Arrangement, Tranche One                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting percentage       33.33%            
Restricted Stock | Long Term Incentive Plan | Share-Based Payment Arrangement, Tranche Three                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting percentage       33.33%            
Restricted Stock | Long Term Incentive Plan | Share-Based Payment Arrangement, Tranche Two                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Vesting percentage       33.33%            
Directors Stock Plan | Long Term Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock based compensation expense | $       $ 1,057 $ 1,174 $ 1,194        
Shares of stock granted under the LTIP to non-executive directors (in shares)       28,112 28,512 41,313        
Weighted average fair value grant price (in dollars per share) | $ / shares     $ 37.61 $ 37.61 $ 41.17 $ 28.91